🇺🇸 Crystalloid in United States

68 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Renal Failure Acute — 21 reports (30.88%)
  2. Drug Interaction — 11 reports (16.18%)
  3. Hypotension — 8 reports (11.76%)
  4. Drug Ineffective — 5 reports (7.35%)
  5. Pyrexia — 5 reports (7.35%)
  6. Caesarean Section — 4 reports (5.88%)
  7. Cardiac Arrest — 4 reports (5.88%)
  8. Heart Rate Increased — 4 reports (5.88%)
  9. Areflexia — 3 reports (4.41%)
  10. Blood Creatine Phosphokinase Increased — 3 reports (4.41%)

Source database →

Crystalloid in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Crystalloid approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Crystalloid in United States?

Tanta University is the originator. The local marketing authorisation holder may differ — check the official source linked above.